KRRO VS ZYXI Stock Comparison

PerformanceEarningsVolatilityForecastSentimentTechnicalsProfitDividend
PerformanceEarningsVolatilityForecastSentimentTechnicalsProfitDividend

Performance

KRRO
100/100

KRRO returned 192.66% in the last 12 months. Based on SPY's performance of 13.09%, its performance is above average giving it a score of 100 of 100.

ZYXI
100/100

ZYXI returned 26.01% in the last 12 months. Based on the other stocks in its sector with an average return of -7.39%, its performance is above average giving it a grade of 100 of 100.

Earnings

KRRO
100/100

KRRO has missed earnings 0 times in the last 20 quarters.

ZYXI
24/100

ZYXI has missed earnings 4 times in the last 20 quarters.

Volatility

KRRO
100/100

KRRO has had a higher than average amount of volatility over the last 12 months giving it a score of 100 of 100.

ZYXI
56/100

ZYXI has had a higher than average amount of volatility over the last 12 months giving it a grade of 55 of 100.

Forecast

KRRO

"Forecast" not found for KRRO

ZYXI
75/100

1 analysts offer 12-month price forecasts for ZYXI. Together, they have an average target of 18, the most optimistic forecast put ZYXI at 18 within 12-months and the most pessimistic has ZYXI at 18.

Sentiment

KRRO

"Sentiment" not found for KRRO

ZYXI
66/100

ZYXI had a bullish sentiment score of 66.34% across Twitter and StockTwits over the last 12 months. It had an average of 10.80 posts, 99.52 comments, and 227.58 likes per day.

Technicals

KRRO

"Technicals" not found for KRRO

ZYXI
10/100

ZYXI receives a 10 of 100 based on 14 indicators. 0 are bullish, 12 are bearish.

Profit

KRRO

"Profit" not found for KRRO

ZYXI
58/100

Out of the last 20 quarters, ZYXI has had 14 profitable quarters and has increased their profits year over year on 7 of them.

Dividend

KRRO

"Dividend" not found for KRRO

ZYXI
15/100

ZYXI's most recent dividend was $0.06 per share, based on a share price of $9.40. It was a payout ratio of 96.13% compared to their total earnings.

All score calculations are broken down here to help you make more informed investing decisions

Korro Bio, Inc. Common Stock Summary

Nasdaq / KRRO
Healthcare
Biotechnology
Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.

ZYNEX INC Summary

Nasdaq / ZYXI
Healthcare
Medical - Distribution
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.